Company of the Year BioMS steps into the Canadian biotechnology limelight
The Faces of Canadian Biotech
When Clifford and Kevin Giese first founded BioMS Medical, they didn’t have a clue what success in the biotechnology space might look like. But that didn’t stop the seasoned entrepreneurs from instinctively planning for it.
“We came in very naïve... except that, at the end of the day,we knew our [drug] compound worked. But we had no idea what a trial would look like, or what was totally involved in getting a trial going. It was a big learning curve for us, but we always tried to plan for success,” says Clifford Giese, Chairman of the Board of BioMS Medical Corp., of Edmonton. “That took us down a lot of different roads... and some very expensive roads.”
|
|
Canada’s biotech enviroment – Our experts weigh in
To get a handle on the state of the current biotechnology industry in Canada, Bio Business consulted several company and association leaders to gain their unique perspectives. Below, our panel discusses everything from the lack of funding in the Canadian industry and the current tax environment, to human resources and talent issues most affecting their businesses.
|
|
|
|
|
Transparency and risk management rank high for investors
 Transparency and risk management are considered by investors to be just as important as performance when deciding whether to retain their managers of alternative investments, according to a major new report by PricewaterhouseCoopers (PwC).
|
|
|
|
Most Canadian entrepreneurs lack confidence in their brand identity
 A new survey from Hewlett-Packard Canada reveals that Canadian small businessowners recognize the benefits of branding, but many are dissatisfied with their own current brand and marketing.
|
|
|
VC investments see largest increase since 2000/01
 Venture capital (VC) investments in Canada reached $2.05B in 2007, a 21% increase over 2006 levels and the largest year-over-year increase since the peak achieved in 2000/2001.
|
|
